Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3H2101
Wed, 06.11.2024
aap Implantate AG
aap Implantate AG ("aap" or "Company") informs that as of October 31, 2024, conversion rights in the amount of 97.4% of the mandatory convertible bond issued in October 2023 were exercised in the context of elective conversions. This means that only 2.6% of the conversion rights have not yet been exercised, which corresponds to an amount of around [ … ]
Mon, 07.10.2024
aap Implantate AG
aap Implantate AG ("aap" or "Company") has reached another important milestone in the transition from MDD (Medical Device Directive 93/42/EEC) to MDR (Medical Device Regulation EU 2017/745). In the week from 9 September 2024 to 13 September 2024, the Notified Body mdc medical device certification GmbH audited aap's quality system according to MDR. [ … ]
Tue, 24.09.2024
aap Implantate AG
BfArM and lead ethics committee approve early end of recruitment
Last patient included on 6 August 2024;
A total of 202 patients were included in the study;
Start of the MDR registration phase
aap Implantate AG ("aap" or "Company") informs that due to the ongoing good results the patient recruitment of the human clinical trial could be terminate [ … ]
Fri, 23.08.2024
aap Implantate AG
Financial year 2023 got off to a promising start for aap Implantate AG ("aap" or "Company"). Sales increased in all regions and exceeded the previous year's figures. The initial upswing lost momentum and the outlook in aap's sales markets gradually deteriorated due to financial difficulties in the healthcare sector and uncertainties about further e [ … ]
Wed, 14.08.2024
aap Implantate AG
Sales: H1/2024 increased by 10% to EUR 6.4 million compared to H1/2023; main growth driver EMEA region
EBITDA: H1/2024 breaks even, Trauma achieves positive EBITDA
aap Implantate AG ("aap" or "Company") looks back on a pleasing first half-year. The Company was able to increase sales and EBITDA compared to the previous year and generate a positive [ … ]
Mon, 15.07.2024
aap Implantate AG
Sales: Q2 at EUR 3.3 million (+14% yoy), main growth driver EMEA (Q2: +44%);
Sales: H1/2024 increased by 10% to EUR 6.4 million compared to H1/2023;
The human clinical trial of the innovative antibacterial implant technology has so far recruited 200 patients, and aap has applied to complete patient recruitment;
aap Implantate AG ("aap" or "Compan [ … ]
Thu, 23.05.2024
aap Implantate AG
Notice to the Holders of the Mandatory Convertible Bond 2023/2028
(ISIN: DE000A351ZH9 / WKN: A351ZH)
aap Implantate AG announces today that the resolution adopted in the vote held without a meeting from March 26, 2024, to March 28, 2024, to cancel the vesting period regarding the conversion of the bonds and to allow a first-time conversion ri [ … ]
Mon, 22.04.2024
aap Implantate AG
Sales increase by 5.6% compared to the same quarter of the previous year
Major order and parts of Q1 sales form strong basis for growth in Q2
Human clinical trial of the innovative antibacterial implant technology is progressing positively and opens up the possibility of an earlier conclusion
aap Implantate AG ("aap" or "Company") continued it [ … ]
Fri, 19.04.2024
aap Implantate AG
The premium to the current share price of EUR 0.8 amounted to 37.5%
The cash inflow will strengthen the company's own resources for the ongoing human clinical trial of the innovative antibacterial implant technology
aap Implantate AG ("aap" or "Company") successfully completed the 10% capital increase announced on March 18, 2024 with exclusion [ … ]
Wed, 03.04.2024
aap Implantate AG
86.03% of the nominal amount and the votes of all outstanding bonds participated in the vote
Approval by 100% of the votes cast
aap Implantate AG ("aap" or "Company") successfully completed the vote without a meeting of bondholders on an amendment to the terms and conditions of the Bonds with an approval of 100% of the votes cast and the nominal v [ … ]